CN Stock MarketDetailed Quotes

605507 Guobang Pharma Ltd.

Watchlist
  • 17.93
  • -0.04-0.22%
Market Closed May 31 15:00 CST
10.02BMarket Cap16.26P/E (TTM)

Guobang Pharma Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guobang Pharma Ltd. Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 16, 2024

Revenue(YoY)

1.34B

-5.07%
EPS(YoY)

0.36

+2.86%
Analyst Rating

Strong Buy

Jun 1, 2024

Guobang Pharma Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 7.521B--
--2024/FY-- / 5.907B--
--2023/FY5.349B / 5.896B--
--2022/FY5.721B / 5.402B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 7.521B--
--2024/FY-- / 5.907B--
--2023/FY5.349B / 5.896B--
--2022/FY5.721B / 5.402B--

Guobang Pharma Ltd. Earnings Reports

  • Summary of Guobang Pharmaceutical\'s 2023 Annual Report

    Apr 15 11:00

  • Guobang Pharmaceutical 2023 Annual Report

    Apr 15 11:00

  • Guobang Pharmaceutical\'s 2024 First Quarter Report

    Apr 15 11:00

  • Guobang Pharmaceutical\'s report for the third quarter of 2023

    Oct 18, 2023 11:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 1, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg